FI101597B1 - Menetelmä kylmäkuivatun koostumuksen valmistamiseksi käytettäväksi potilaan valodynaamisessa hoidossa tai diagnosoinnissa - Google Patents

Menetelmä kylmäkuivatun koostumuksen valmistamiseksi käytettäväksi potilaan valodynaamisessa hoidossa tai diagnosoinnissa

Info

Publication number
FI101597B1
FI101597B1 FI902966A FI902966A FI101597B1 FI 101597 B1 FI101597 B1 FI 101597B1 FI 902966 A FI902966 A FI 902966A FI 902966 A FI902966 A FI 902966A FI 101597 B1 FI101597 B1 FI 101597B1
Authority
FI
Finland
Prior art keywords
preparing
photodynamic therapy
diagnosis
patient
lyophilized composition
Prior art date
Application number
FI902966A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI902966A0 (fi
FI101597B (fi
Inventor
Bruce E Haeger
James R Lawter
Vijay H Naringrekar
Michael C Cucolo
Original Assignee
Quadra Logic Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23442747&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI101597(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Quadra Logic Tech Inc filed Critical Quadra Logic Tech Inc
Publication of FI902966A0 publication Critical patent/FI902966A0/fi
Application granted granted Critical
Publication of FI101597B publication Critical patent/FI101597B/fi
Publication of FI101597B1 publication Critical patent/FI101597B1/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI902966A 1989-06-14 1990-06-13 Menetelmä kylmäkuivatun koostumuksen valmistamiseksi käytettäväksi potilaan valodynaamisessa hoidossa tai diagnosoinnissa FI101597B1 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/366,374 US5059619A (en) 1989-06-14 1989-06-14 Stable freeze-dried polyhematoporphyrin ether/ester
US36637489 1989-06-14

Publications (3)

Publication Number Publication Date
FI902966A0 FI902966A0 (fi) 1990-06-13
FI101597B FI101597B (fi) 1998-07-31
FI101597B1 true FI101597B1 (fi) 1998-07-31

Family

ID=23442747

Family Applications (1)

Application Number Title Priority Date Filing Date
FI902966A FI101597B1 (fi) 1989-06-14 1990-06-13 Menetelmä kylmäkuivatun koostumuksen valmistamiseksi käytettäväksi potilaan valodynaamisessa hoidossa tai diagnosoinnissa

Country Status (26)

Country Link
US (1) US5059619A (enExample)
EP (1) EP0402637B1 (enExample)
JP (1) JP3112918B2 (enExample)
KR (1) KR0164845B1 (enExample)
CN (1) CN1058388C (enExample)
AR (1) AR244549A1 (enExample)
AT (1) ATE144703T1 (enExample)
AU (1) AU625549B2 (enExample)
CA (1) CA2018751C (enExample)
CZ (1) CZ283309B6 (enExample)
DD (1) DD295087A5 (enExample)
DE (1) DE69029012T2 (enExample)
DK (1) DK0402637T3 (enExample)
ES (1) ES2095846T3 (enExample)
FI (1) FI101597B1 (enExample)
GR (1) GR3021511T3 (enExample)
HU (1) HU215522B (enExample)
IE (1) IE902137A1 (enExample)
IL (1) IL94448A (enExample)
NO (1) NO176645C (enExample)
NZ (1) NZ233953A (enExample)
PL (1) PL164744B1 (enExample)
PT (1) PT94344B (enExample)
RU (1) RU2019990C1 (enExample)
TW (1) TW225475B (enExample)
ZA (1) ZA904599B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5418130A (en) 1990-04-16 1995-05-23 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
US6187572B1 (en) 1990-04-16 2001-02-13 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
PL165249B1 (pl) * 1991-10-29 1994-11-30 Wojskowa Akad Tech Sposób otrzymywania soli kompleksowych hematoporfiryny i jej pochodnych PL PL PL PL PL PL PL
US5244914A (en) * 1992-04-27 1993-09-14 American Cyanamid Company Stable porfimer sodium compositions and methods for their manufacture
NO180167C (no) * 1994-09-08 1997-02-26 Photocure As Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
US5660181A (en) * 1994-12-12 1997-08-26 Physical Optics Corporation Hybrid neural network and multiple fiber probe for in-depth 3-D mapping
GB9512854D0 (en) * 1995-06-23 1995-08-23 Wellcome Found Novel formulation
US5958104A (en) * 1997-09-11 1999-09-28 Nonomura; Arthur M. Methods and compositions for enhancing plant growth
CA2221912A1 (en) * 1997-11-21 1999-05-21 David Dolphin Photosensitizers with improved biodistribution and light-absorbing properties
AU2210402A (en) 2000-11-29 2002-06-11 Norwegian Radium Hospital Res Photochemical internalization for virus-mediated molecule delivery into the cyosol
AU2085302A (en) 2000-11-29 2002-06-11 Norwegian Radium Hospital Res Photochemical internalization for delivery of molecules into the cytosol
US7175611B2 (en) 2002-06-05 2007-02-13 Mark Alan Mitchnick Antimicrobial release system
RU2223963C1 (ru) * 2002-06-25 2004-02-20 Московская государственная академия тонкой химической технологии им. М.В. Ломоносова Способ получения производного гематопорфирина
CN103961323B (zh) * 2013-02-05 2017-10-17 浙江海正药业股份有限公司 一种注射用hpph冻干粉针制剂及其制备方法
US9733187B2 (en) * 2015-03-06 2017-08-15 King Saud University Method of detecting bladder cancer by optical analysis of bodily fluids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2858320A (en) * 1956-04-02 1958-10-28 Baxter Laboratories Inc Stable hematoporphyrin
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4753958A (en) * 1985-02-07 1988-06-28 University Of Cal Photochemotherapy of epithelial diseases with derivatives of hematoporphyrins
DK168690B1 (da) * 1985-04-30 1994-05-24 Nippon Petrochemicals Co Ltd Farmaceutiske præparater til detektion og/eller behandling af pattedyrtumorer
US4882234A (en) * 1986-11-12 1989-11-21 Healux, Inc. Storage-stable porphin compositions and a method for their manufacture
US4968715A (en) * 1988-07-06 1990-11-06 Health Research, Inc. Use of purified hematoporphyrin trimers in photodynamic therapy

Also Published As

Publication number Publication date
CS9002889A2 (en) 1991-11-12
GR3021511T3 (en) 1997-01-31
CZ283309B6 (cs) 1998-02-18
IE902137L (en) 1990-12-14
RU2019990C1 (ru) 1994-09-30
NO902634D0 (no) 1990-06-13
PT94344B (pt) 1997-04-30
ES2095846T3 (es) 1997-03-01
AR244549A1 (es) 1993-11-30
IL94448A0 (en) 1991-03-10
NO176645C (no) 1995-05-10
HU215522B (hu) 1999-01-28
AU625549B2 (en) 1992-07-16
CN1058388C (zh) 2000-11-15
EP0402637A2 (en) 1990-12-19
AU5708990A (en) 1990-12-20
NO176645B (no) 1995-01-30
JPH0331283A (ja) 1991-02-12
KR910000146A (ko) 1991-01-29
DD295087A5 (de) 1991-10-24
NO902634L (no) 1990-12-17
IL94448A (en) 1994-06-24
ATE144703T1 (de) 1996-11-15
FI902966A0 (fi) 1990-06-13
CA2018751C (en) 2001-08-21
DK0402637T3 (da) 1997-04-07
TW225475B (enExample) 1994-06-21
KR0164845B1 (ko) 1999-01-15
ZA904599B (en) 1991-04-24
NZ233953A (en) 1992-08-26
PL164744B1 (pl) 1994-10-31
HU903850D0 (en) 1990-11-28
DE69029012T2 (de) 1997-02-27
CN1047973A (zh) 1990-12-26
EP0402637B1 (en) 1996-10-30
IE902137A1 (en) 1991-01-02
CA2018751A1 (en) 1990-12-14
JP3112918B2 (ja) 2000-11-27
DE69029012D1 (de) 1996-12-05
EP0402637A3 (en) 1991-04-03
HUT54888A (en) 1991-04-29
FI101597B (fi) 1998-07-31
US5059619A (en) 1991-10-22
PT94344A (pt) 1991-02-08

Similar Documents

Publication Publication Date Title
FI922151A0 (fi) Metall-peptidkompositioner och metoder foer stimulering av haortillvaext.
FI101597B1 (fi) Menetelmä kylmäkuivatun koostumuksen valmistamiseksi käytettäväksi potilaan valodynaamisessa hoidossa tai diagnosoinnissa
ATE92930T1 (de) Saponinkomplexe mit phospholipiden und sie enthaltende pharmazeutische und kosmetische zusammensetzungen.
FI885318A7 (fi) Polymeerisiä superabsorbenttikoostumuksia ja menetelmiä niiden valmistamiseksi
LU91498I2 (fr) Etanercept et ses dérivés pharmaceutiquement acceptables.
AU1808488A (en) Compounds for the treatment of alzheimer's disease
SG48298A1 (en) Saccharin deriatives useful as proteolytic enzymeinhibitors and preparation of
ES2157886T3 (es) Composiciones tensioactivas y procedimientos.
FI895141A0 (fi) Kelatmedel med orto-ligerande funktionalitet och deras komplexer.
FI891812L (fi) Mikro-organismeja tappava/mikro-organismien kasvua estävä koostumus ja menetelmä sellaisen valmistamiseksi
AU536582B2 (en) Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
FI910924A7 (fi) Uusia propanamiineja, niiden valmistus ja niiden käyttö terapeuttisiintarkoituksiin, erityisesti ripulilääkkeenä
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
EP0403530A4 (en) Storage-stable compositions and methods for treating keratinous tissue
GR3005231T3 (enExample)
DE3473826D1 (en) N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
SE8400118L (sv) Substituerade karboxi-tiazolo/3,2-a/pyrimidinderivat och forfarande for deras framstellning
ATE70440T1 (de) Verwendung von anipamil als artereosklerosemittel.
FI913531A7 (fi) 1,2-bentsopyronijohdannaisten käyttö ihmisen pahanlaatuisten kasvainte n hoitoon
ATE96035T1 (de) Verwendung eines polypeptides mit gammainterferon-aktivitaet zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von primitivem pleura-krebs.
ATE89727T1 (de) Optisch reines dexniguldipin und dessen derivate zur behandlung von tumorerkrankungen.
IT1248485B (it) Derivati della 1,4-benzotiazina ad azione immunostimolante e immonomodulatrice

Legal Events

Date Code Title Description
SPCL Withdrawal, rejection or dismissal of a supplementary protection certificate

Spc suppl protection certif: L19990012

FG Patent granted

Owner name: AXCAN PHARMA (IRELAND) LIMITED

PC Transfer of assignment of patent

Owner name: AXCAN PHARMA (IRELAND) LIMITED